{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:03:20Z","timestamp":1791849800478,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Progetto di Ricerca di Interesse Nazionale"},{"name":"Progetti del Ministero della Salute","award":["GR-2010-2315007"],"award-info":[{"award-number":["GR-2010-2315007"]}]},{"name":"Minister of Health","award":["GR-2011-02351457"],"award-info":[{"award-number":["GR-2011-02351457"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association, United States","doi-asserted-by":"publisher","award":["NIRG-11-204588"],"award-info":[{"award-number":["NIRG-11-204588"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004486","name":"Cassa di Risparmio di Perugia","doi-asserted-by":"crossref","award":["(2014.0258.021)"],"award-info":[{"award-number":["(2014.0258.021)"]}],"id":[{"id":"10.13039\/501100004486","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neurobiolaging.2016.08.025","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T19:12:31Z","timestamp":1473361951000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Epilepsy, amyloid-\u03b2, and D1 dopamine receptors: a possible pathogenetic link?"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-4221","authenticated-orcid":false,"given":"Cinzia","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"D'Amelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tantucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Romigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Siliquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virve","family":"Cavallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Mazzocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8369-1561","authenticated-orcid":false,"given":"Annalisa","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Eusebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola B.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2016.08.025_bib1","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.yebeh.2003.11.005","article-title":"Effects of epileptiform EEG discharges on cognitive function: is the concept of \u201ctransient cognitive impairment\u201d still valid?","volume":"5","author":"Aldenkamp","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","article-title":"Incidence and predictors of seizures in patients with Alzheimer's disease","volume":"47","author":"Amatniek","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.neurobiolaging.2007.11.010","article-title":"Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease","volume":"30","author":"Ambree","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fncel.2013.00157","article-title":"The role of dopamine signaling in epileptogenesis","volume":"7","author":"Bozzi","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12017-013-8241-2","article-title":"Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease","volume":"15","author":"Cavallucci","year":"2013","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/6374","article-title":"Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice","volume":"2","author":"Chapman","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib8","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","article-title":"Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease","volume":"25","author":"Chin","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nn.2709","article-title":"Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease","volume":"14","author":"D'Amelio","year":"2011","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2004.05.107","article-title":"Increased seizure threshold and severity in young transgenic CRND8 mice","volume":"367","author":"Del Vecchio","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrn2822","article-title":"New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?","volume":"11","author":"Deng","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0079-6123(07)63041-6","article-title":"Epileptogenesis in the dentate gyrus: a critical perspective","volume":"163","author":"Dudek","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib12","article-title":"Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices","volume":"41","author":"Fa","year":"2010","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib13","doi-asserted-by":"crossref","first-page":"e15725","DOI":"10.1371\/journal.pone.0015725","article-title":"Abeta40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease","volume":"5","author":"Gao","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00231156","article-title":"Bicuculline-induced epileptogenesis in the human neocortex maintained in\u00a0vitro","volume":"83","author":"Hwa","year":"1991","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib17","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1074\/jbc.M110.177790","article-title":"Activation of D1\/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers","volume":"286","author":"Jurgensen","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0079-6123(02)35010-6","article-title":"Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits","volume":"135","author":"Kotloski","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12017-009-8076-z","article-title":"Epileptic seizures in AD patients","volume":"12","author":"Larner","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib21","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib22","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1471-4159.2007.04869.x","article-title":"Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models","volume":"103","author":"Ma","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1098\/rstb.2002.1233","article-title":"AMPA receptor trafficking and long-term potentiation","volume":"358","author":"Malinow","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer's disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib25","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","article-title":"Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy","volume":"29","author":"Minkeviciene","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib26","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1113\/jphysiol.2009.172445","article-title":"What is remembered? Role of attention on the encoding and retrieval of hippocampal representations","volume":"587","author":"Muzzio","year":"2009","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib27","first-page":"63","article-title":"Age-related changes of protein SUMOylation balance in the A\u03b2PP Tg2576 mouse model of Alzheimer's disease","volume":"5","author":"Nistic\u00f2","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib28","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.1523\/JNEUROSCI.2829-05.2005","article-title":"Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice","volume":"25","author":"Palop","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib30","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1073\/pnas.1133381100","article-title":"Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits","volume":"100","author":"Palop","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib32","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2217\/bmm.11.48","article-title":"Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease","volume":"5","author":"Parnetti","year":"2011","journal-title":"Biomark. Med."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib34","doi-asserted-by":"crossref","first-page":"15951","DOI":"10.1073\/pnas.0913875107","article-title":"AMPA receptors are exocytosed in stimulated spines and adjacent dendrites in a Ras-ERK-dependent manner during long-term potentiation","volume":"107","author":"Patterson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib35","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1523\/JNEUROSCI.2773-05.2005","article-title":"Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe\/PS1DeltaE9 transgenic mice","volume":"25","author":"Perez","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0079-6123(02)35008-8","article-title":"Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy","volume":"135","author":"Pitkanen","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(02)00073-X","article-title":"Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy","volume":"1","author":"Pitkanen","year":"2002","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.npp.1301485","article-title":"Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens","volume":"33","author":"Preda","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib39","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.62.5_suppl_2.S24","article-title":"Special considerations in treating the elderly patient with epilepsy","volume":"62","author":"Ramsay","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib40","first-page":"CD008782","article-title":"Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","author":"Ritchie","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib41","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archneurol.2009.130","article-title":"Seizures in Alzheimer disease: who, when, and how common?","volume":"66","author":"Scarmeas","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib42","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1046\/j.1471-4159.1994.63051872.x","article-title":"Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity","volume":"63","author":"Sheng","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib43","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.2610-10.2011","article-title":"Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation","volume":"31","author":"Shipton","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib44","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3892\/mmr.2014.1977","article-title":"Expression of \u03b2-amyloid precursor protein in refractory epilepsy","volume":"9","author":"Sima","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib45","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1073\/pnas.1311783110","article-title":"ERK regulation of phosphodiesterase 4 enhances dopamine-stimulated AMPA receptor membrane insertion","volume":"110","author":"Song","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib46","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In\u00a0vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib47","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib49","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.neuroscience.2007.04.056","article-title":"Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide","volume":"147","author":"Trabace","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib50","doi-asserted-by":"crossref","first-page":"e4590","DOI":"10.1371\/journal.pone.0004590","article-title":"Improved learning and memory in aged mice deficient in amyloid beta-degrading neutral endopeptidase","volume":"4","author":"Walther","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1756-6606-3-32","article-title":"Altered synaptic plasticity in the mossy fibre pathway of transgenic mice expressing mutant amyloid precursor protein","volume":"3","author":"Witton","year":"2010","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib52","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11011-013-9424-0","article-title":"The preventive effect of NR2B and NR2D-containing NMDAR antagonists on A\u03b2-induced LTP disruption in the dentate gyrus of rats","volume":"28","author":"Zhang","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neurobiolaging.2016.08.025_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(02)00897-8","article-title":"Ras and Rap control AMPA receptor trafficking during synaptic plasticity","volume":"110","author":"Zhu","year":"2002","journal-title":"Cell"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016302032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016302032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T04:38:36Z","timestamp":1568349516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458016302032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":54,"alternative-id":["S0197458016302032"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.025","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy, amyloid-\u03b2, and D1 dopamine receptors: a possible pathogenetic link?","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}